Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Virtus LifeSci Biotech Clinical Trials ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has returned 7.95% so far this year and 141.32% over the past 12 months. Over the last ten years, BBC has returned 8.41% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Virtus LifeSci Biotech Clinical Trials ETF
- 1D
- 7.67%
- 1M
- -1.98%
- YTD
- 7.95%
- 6M
- 55.07%
- 1Y
- 141.32%
- 3Y*
- 25.09%
- 5Y*
- -3.63%
- 10Y*
- 8.41%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Dec 17, 2014, BBC's average daily return is +0.05%, while the average monthly return is +0.91%. At this rate, your investment would double in approximately 6.4 years.
Historically, 52% of months were positive and 48% were negative. The best month was Dec 2023 with a return of +25.1%, while the worst month was Jan 2016 at -33.9%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 9 months.
On a daily basis, BBC closed higher 52% of trading days. The best single day was Nov 9, 2016 with a return of +10.7%, while the worst single day was Mar 16, 2020 at -12.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.92% | 3.98% | -1.98% | 7.95% | |||||||||
| 2025 | -3.85% | -11.63% | -13.78% | 8.84% | -4.71% | 6.21% | 12.11% | 4.80% | 20.24% | 18.19% | 17.27% | 3.65% | 63.77% |
| 2024 | 3.81% | 18.46% | -3.12% | -10.43% | 1.62% | -4.73% | 14.23% | -2.88% | -0.29% | 1.75% | -3.40% | -11.95% | -1.11% |
| 2023 | 10.58% | -9.56% | -12.29% | 5.00% | 5.69% | -1.50% | 0.52% | -10.85% | -8.61% | -8.99% | 9.85% | 25.08% | -1.80% |
| 2022 | -22.31% | -4.80% | -1.94% | -21.07% | -12.26% | 11.61% | 11.18% | 5.54% | -3.01% | 5.28% | -1.60% | -1.85% | -35.13% |
| 2021 | 6.07% | 3.39% | -5.53% | -1.30% | -5.29% | 4.00% | -11.59% | 8.13% | -4.27% | -2.93% | -8.49% | -5.10% | -22.31% |
Benchmark Metrics
Virtus LifeSci Biotech Clinical Trials ETF has an annualized alpha of -2.58%, beta of 1.21, and R² of 0.31 versus S&P 500 Index. Calculated based on daily prices since December 18, 2014.
- This ETF participated in 145.57% of S&P 500 Index downside but only 121.01% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.31 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -2.58%
- Beta
- 1.21
- R²
- 0.31
- Upside Capture
- 121.01%
- Downside Capture
- 145.57%
Expense Ratio
BBC has an expense ratio of 0.79%, placing it in the medium range.
Return for Risk
Risk / Return Rank
BBC ranks 97 for risk / return — in the top 97% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and compare them to a chosen benchmark (S&P 500 Index).
| BBC | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.52 | 0.90 | +2.62 |
Sortino ratioReturn per unit of downside risk | 3.86 | 1.39 | +2.47 |
Omega ratioGain probability vs. loss probability | 1.47 | 1.21 | +0.26 |
Calmar ratioReturn relative to maximum drawdown | 6.54 | 1.40 | +5.14 |
Martin ratioReturn relative to average drawdown | 25.10 | 6.61 | +18.49 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore BBC risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Virtus LifeSci Biotech Clinical Trials ETF provided a 1.57% dividend yield over the last twelve months, with an annual payout of $0.66 per share. The fund has been increasing its distributions for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.66 | $0.66 | $0.24 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.00 | $0.15 |
Dividend yield | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
Monthly Dividends
The table displays the monthly dividend distributions for Virtus LifeSci Biotech Clinical Trials ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.66 | $0.66 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.24 | $0.24 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.08 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Virtus LifeSci Biotech Clinical Trials ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Virtus LifeSci Biotech Clinical Trials ETF was 76.85%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Virtus LifeSci Biotech Clinical Trials ETF drawdown is 30.71%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -76.85% | Feb 9, 2021 | 1046 | Apr 8, 2025 | — | — | — |
| -58.5% | Jul 20, 2015 | 329 | Nov 3, 2016 | 788 | Dec 23, 2019 | 1117 |
| -40.47% | Dec 26, 2019 | 57 | Mar 18, 2020 | 37 | May 11, 2020 | 94 |
| -16.61% | Jun 24, 2020 | 53 | Sep 8, 2020 | 57 | Nov 27, 2020 | 110 |
| -15.83% | Mar 20, 2015 | 29 | Apr 30, 2015 | 20 | May 29, 2015 | 49 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...